Michael Burgess • UCSF Profiles

Michael Burgess, MD, PhD

Title(s)	Assistant Clinical Professor, Medicine
School	School of Medicine
Address	1001 Potrero Ave San Francisco CA 94110
Phone	--
vCard	Download vCard

Biography

Education and Training

University of California, San Francisco	Fellowship	2012	Hematology and Medical Oncology
University of California, San Francisco	Residency	2009	Internal Medicine
David Geffen School of Medicine at UCLA	M.D.	2007	Medicine
University of California, Los Angeles	Ph.D.	2005	Molecular Biology
University of California, Berkeley	B.A.	1997	Molecular and Cell Biology

Overview

Interests

Acute Myeloid Leukemia, Myelodysplastic Syndromes, Multiple Myeloma, Lymphoma, Early Clinical Development, Biomarker Discovery

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS. Blood. 2018 06 14; 131(24):2682-2697. An N, Khan S, Imgruet MK, Gurbuxani SK, Konecki SN, Burgess MR, McNerney ME. PMID: 29592892.

View in: PubMed Mentions: 10 Fields:
Hem Hematology
Translation:Humans Animals Cells
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer. Cell. 2017 02 23; 168(5):817-829.e15. Burgess MR, Hwang E, Mroue R, Bielski CM, Wandler AM, Huang BJ, Firestone AJ, Young A, Lacap JA, Crocker L, Asthana S, Davis EM, Xu J, Akagi K, Le Beau MM, Li Q, Haley B, Stokoe D, Sampath D, Taylor BS, Evangelista M, Shannon K. PMID: 28215705.

View in: PubMed Mentions: 64 Fields:
Cel Cell Biology
Translation:Humans Animals Cells
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia. Nat Med. 2017 Mar; 23(3):301-313. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR, Fenouille N, Bassil CF, Ben-Sahra I, Benajiba L, Alexe G, Ramos A, Pikman Y, Conway AS, Burgess MR, Li Q, Luciano F, Auberger P, Galinsky I, DeAngelo DJ, Stone RM, Zhang Y, Perkins AS, Shannon K, Hemann MT, Puissant A, Stegmaier K. PMID: 28191887; PMCID: PMC5540325.

View in: PubMed Mentions: 29 Fields:
Med Medicine (General)Mol Molecular Biology
Translation:Humans Cells
Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis. Elife. 2015 Jul 20; 4. Wong JC, Weinfurtner KM, Alzamora Mdel P, Kogan SC, Burgess MR, Zhang Y, Nakitandwe J, Ma J, Cheng J, Chen SC, Ho TT, Flach J, Reynaud D, Passegué E, Downing JR, Shannon K. PMID: 26193121.

View in: PubMed Mentions: 6 Fields:
Bio Biology
Translation:Humans Animals Cells
Preclinical efficacy of MEK inhibition in Nras-mutant AML. Blood. 2014 Dec 18; 124(26):3947-55. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR, Burgess MR, Hwang E, Firestone AJ, Huang T, Xu J, Zuber J, Bohin N, Wen T, Kogan SC, Haigis KM, Sampath D, Lowe S, Shannon K, Li Q. PMID: 25361812; PMCID: PMC4271180.

View in: PubMed Mentions: 39 Fields:
Hem Hematology
Translation:Humans Animals Cells
MAGI-2 scaffold protein is critical for kidney barrier function. Proc Natl Acad Sci U S A. 2014 Oct 14; 111(41):14876-81. Balbas MD, Burgess MR, Murali R, Wongvipat J, Skaggs BJ, Mundel P, Weins A, Sawyers CL. PMID: 25271328.

View in: PubMed Mentions: 20 Fields:
Sci Science
Translation:Animals Cells
PLC-γ and PI3K link cytokines to ERK activation in hematopoietic cells with normal and oncogenic Kras. Sci Signal. 2013 Dec 03; 6(304):ra105. Diaz-Flores E, Goldschmidt H, Depeille P, Ng V, Akutagawa J, Krisman K, Crone M, Burgess MR, Williams O, Houseman B, Shokat K, Sampath D, Bollag G, Roose JP, Braun BS, Shannon K. PMID: 24300897.

View in: PubMed Mentions: 8 Fields:
Cel Cell Biology Phy Physiology Sci Science
Translation:Animals Cells
Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants. Proc Natl Acad Sci U S A. 2006 Dec 19; 103(51):19466-71. Skaggs BJ, Gorre ME, Ryvkin A, Burgess MR, Xie Y, Han Y, Komisopoulou E, Brown LM, Loo JA, Landaw EM, Sawyers CL, Graeber TG. PMID: 17164333.

View in: PubMed Mentions: 66 Fields:
Sci Science
Translation:Animals Cells
Treating imatinib-resistant leukemia: the next generation targeted therapies. ScientificWorldJournal. 2006 Aug 11; 6:918-30. Burgess MR, Sawyers CL. PMID: 16906325.

View in: PubMed Mentions: 10 Fields:
Med Medicine (General)Sci Science Tec Technology
Translation:Humans Cells
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance. Proc Natl Acad Sci U S A. 2005 Mar 01; 102(9):3395-400. Burgess MR, Skaggs BJ, Shah NP, Lee FY, Sawyers CL. PMID: 15705718.

View in: PubMed Mentions: 85 Fields:
Sci Science
Translation:Humans Cells